Literature DB >> 19806791

Comparative proteomic analysis of mouse melanoma cell line B16, a metastatic descendant B16F10, and B16 overexpressing the metastasis-associated tyrosine phosphatase PRL-3.

Sang Hee Kim1, Yongmo Kim, Moonil Kim, Dae Shick Kim, Sang Chul Lee, Seung-Wook Chi, Do Hee Lee, Sung Goo Park, Byoung Chul Park, Kwang-Hee Bae, Sunghyun Kang.   

Abstract

Metastasis is a complex, multistep process by which a cancer cell leaves the primary tumor, travels to a distant site via the circulatory system, and establishes a secondary cancer. A deeper understanding of the molecular events underlying metastasis will provide information that will be useful for the development of new diagnostic and therapeutic strategies. The B16 and B16F10 mouse melanoma cell lines are widely used as model system for studying many aspects of cancer biology including metastasis. Compared with B16, which has a low metastatic potential, the highly metastatic cell line B16F10 displayed a higher metastatic ability along with higher expression levels of the metastasis-associated phosphatase of regenerating liver-3 (PRL-3). B16 cells transfected with PRL-3 cDNA (B16-PRL3) had metastatic abilities comparable to those of Bl16F10 cells. To study the molecular mechanisms that underlie metastasis, the proteomes of the B16, B16F10, and B16-PRL3 cell lines were compared using two-dimensional differential in-gel electrophoresis. Proteins that varied significantly in levels between these cell lines were selected and identified using mass spectrometry. Interestingly, many proteins, especially those present in membrane fractions, were similarly up- or downregulated in both the Bl16F10 and B16-PRL3 cells lines compared to B16 cell lines. The list of similarly regulated proteins included heat shock protein 70, fascin-1, septin-6, ATP synthase beta subunit, and bone morphogenic protein receptor type IB. These proteins may play a causal role in PRL-3-mediated metastasis. These investigations open an avenue for the further characterization of the molecular mechanisms that underlie metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806791     DOI: 10.3727/096504009789745494

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  10 in total

1.  Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.

Authors:  Bradley D Shields; Brian Koss; Erin M Taylor; Aaron J Storey; Kirk L West; Stephanie D Byrum; Samuel G Mackintosh; Rick Edmondson; Fade Mahmoud; Sara C Shalin; Alan J Tackett
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

2.  Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression.

Authors:  Yosuke Funato; Daisuke Yamazaki; Shin Mizukami; Lisa Du; Kazuya Kikuchi; Hiroaki Miki
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

3.  CDH22 expression is reduced in metastatic melanoma.

Authors:  Brad Piche; Shahram Khosravi; Magdalena Martinka; Vincent Ho; Gang Li
Journal:  Am J Cancer Res       Date:  2010-12-10       Impact factor: 6.166

4.  PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.

Authors:  Guennadi Kozlov; Yosuke Funato; Yu Seby Chen; Zhidian Zhang; Katalin Illes; Hiroaki Miki; Kalle Gehring
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

5.  Studies of Secondary Melanoma on C57BL/6J Mouse Liver Using 1H NMR Metabolomics.

Authors:  Ju Feng; Nancy G Isern; Sarah D Burton; Jian Zhi Hu
Journal:  Metabolites       Date:  2013-10-31

6.  Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.

Authors:  Cheng-Jeng Tai; Tzu-Cheng Su; Ming-Chung Jiang; Hung-Chang Chen; Shing-Chuan Shen; Woan-Ruoh Lee; Ching-Fong Liao; Ying-Chun Chen; Shu-Hui Lin; Li-Tzu Li; Ko-Hung Shen; Chung-Min Yeh; Kun-Tu Yeh; Ching-Hsiao Lee; Hsin-Yi Shih; Chun-Chao Chang
Journal:  J Transl Med       Date:  2013-01-31       Impact factor: 5.531

7.  Fascin 1 is transiently expressed in mouse melanoblasts during development and promotes migration and proliferation.

Authors:  Yafeng Ma; Ang Li; William J Faller; Silvana Libertini; Florencia Fiorito; David A Gillespie; Owen J Sansom; Shigeko Yamashiro; Laura M Machesky
Journal:  Development       Date:  2013-05       Impact factor: 6.868

8.  Dermal fibroblasts induce cell cycle arrest and block epithelial-mesenchymal transition to inhibit the early stage melanoma development.

Authors:  Linli Zhou; Kun Yang; R Randall Wickett; Yuhang Zhang
Journal:  Cancer Med       Date:  2016-04-06       Impact factor: 4.452

9.  Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis.

Authors:  Ping Zhou; Jiaqi Qin; Yuan Li; Guoxia Li; Yinsong Wang; Ning Zhang; Peng Chen; Chunyu Li
Journal:  J Exp Clin Cancer Res       Date:  2017-09-02

10.  MMP-9 and IL-1β as Targets for Diatoxanthin and Related Microalgal Pigments: Potential Chemopreventive and Photoprotective Agents.

Authors:  Luigi Pistelli; Clementina Sansone; Arianna Smerilli; Marco Festa; Douglas M Noonan; Adriana Albini; Christophe Brunet
Journal:  Mar Drugs       Date:  2021-06-22       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.